Please enable Javascript to get a taste of that HopiumĀ šŸ‘¼

Bio-Rad Laboratories, Inc

Financials

We've grouped the latest 4 financial reports for BIO. You can view and compare their Income Statement, Balance Sheet, and Cash Flow.

Income Statement2017201820192020
Total Revenue2121211000455159200046009980005058794000
Cost of Revenue1825196000222186000019042880001937471000
Gross Margin1187703000122315100012569960001437822000
Research & Development250157000199196000202710000226598000
Selling, General and Administrative----
Other Operating Expense----
Total Operating Expense----
Operating Income119250000-103341000229661000410957000
Interest Income110000026600000305000004491393000
Interest Expense23014000239620002341600021861000
Net Interest Incomee-21914000-23962000-23416000-21861000
Other Income Expense----
Non-recurring Items----
Other Non-operating Income10697000365930002609400024488000
Income before Provision for income taxes9780500051265900022610810004907638000
Tax Provision-244440001470450005024060001101371000
Net Income12224900036561400017586750003806267000
Effect of accounting charges----
Minority Interest----
Provision for income taxes----
Non-recurring items----
Other Items----
Discontinued Operations----
Preferred Stock Dividends----
EBIT12081900053662100022844970004929499000
Balance Sheet2017201820192020
Assets
Cash, Cash Equivalents & Short-term investments7549780008447960001114645000991118000
Cash & Cash Equivalents----
Other Short-term Investments371154000413270000453973000328913000
Receivables----
Inventory594804000583815000554007000622253000
Other Current Assets1032500096150001094000010859000
Total Current Assets1976649000202347800021801550002139835000
PPE493496000508690000499339000491371000
Non-current Marketable Securities1027736000265570900046382050009561140000
Other Non-current assets94949000702980007963600086723000
total non-current assets22963630003590147000583056500010840863000
Goodwill506100000219800000264131000291900000
Other Intangible Assets680213000352923000409656000491413000
deferred long-term asset charges----
Total Assets42730120005611100000800885900012972618000
Liabilities
Accounts Payable----
Current Debt42000049300042617200036507000
Other Current Liabilties12728800010121800086840000173570000
Total Current Liabilities502696000450795000905495000631536000
Long Term Debt437320000441193000129277200017698000
Non-Current Deferred Liabilties----
Negative Goodwill----
Other Non-Current Liabilities183276000147766000160923000196971000
total non-current liabilities91388500012092050002549230002555942000
Total capital lease obligations--1120000011000000
Total Liabilities1342762000159073700022538020003092678000
Shareholder's Equity
Common Stock----
Share premium----
Preferred Stock----
Retained Earnings----
Additional Paid-in Capital----
Gains/Losses not affecting retained earnings----
Treasury Stock-217000-49129000-38397000-99907000
Total Shareholders' Equity2930250000402033100057550570009879940000
Total Liabilities and Shareholders' Equity----
Cash Flow2017201820192020
Cash from Operating Activities
Operating Activities104137000285494000457897000575328000
Other Operating Activities----
Change(increase) in Operating Activities----
Net Income12224900036561400017586750003806267000
Depreciation----
Change in Liabilities----
Change in Inventory4770000012900000-2420000052100000
Change(increase) in Account Receivables----
Change(increase) in Receivables64100000-59700000-160000015000000
Cash from Investing Activities
Investment Activities-175572000-186978000-208889000-60250000
Other Investment Activities----
Investments----
Capital Expenditures1151270001298280009853200098920000
Cash from Financing Activities
Financing Activities341000-48680000-22758000-523041000
Other Financing Activities----
Stock Sale and Purchase----
Dividends----
Net Borrowings----
Change(increase) in Cash----
Change(increase) in Cash and Cash Equivalents-72440000491870002284870004464000
Change(increase) in Net Income----
Change in Exchange Rate-1094000-655000223700012427000
Data source(s): Alpha Vantage